Aviso Financial’s Novo Nordisk NVO Stock Holding History

Aviso Financial’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29.7K	Sell	808 -3,484	-81%	-$165K	﹤0.01%	260
2025 Q4	$218K	Sell	4,292 -25,309	-86%	-$1.29M	0.01%	215
2025 Q3	$1.64M	Sell	29,601 -8,221	-22%	-$481K	0.07%	117
2025 Q2	$2.61M	Buy	37,822 +702	+2%	+$47.8K	0.12%	89
2025 Q1	$2.58M	Buy	37,120 +3,253	+10%	+$269K	0.13%	85
2024 Q4	$2.91M	Buy	33,867 +908	+3%	+$98.2K	0.15%	79
2024 Q3	$3.92M	Buy	32,959 +2,923	+10%	+$390K	0.19%	67
2024 Q2	$4.29M	Buy	+30,036	New	+$3.98M	0.24%	58

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Aviso Financial's NVO Position: Q1 2026 in Review

Aviso Financial reduced its Novo Nordisk (NVO) stake by 81% in Q1 2026, selling an estimated $165K and leaving 808 shares worth $29.7K. The position accounts for ﹤0.01% of the portfolio, ranked #260.

Aviso Financial first reported a position in NVO in Q2 2024 and has held it in 8 quarters since. The position peaked at $4.29M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Aviso Financial held 808 shares of Novo Nordisk worth $29.7K as of Q1 2026.
Aviso Financial sold 3,484 Novo Nordisk shares in Q1 2026, an estimated $165K.
Novo Nordisk made up ﹤0.01% of Aviso Financial's portfolio in Q1 2026, its #260 holding.
Aviso Financial first reported a position in Novo Nordisk in Q2 2024 and has held it in 8 quarters since.
Aviso Financial's Novo Nordisk position peaked at $4.29M in Q2 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Aviso Financial's 13F filing for Q1 2026, filed 14 May 2026.